Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumor necrosis factor alpha antibody infliximab

Схожие документы

• Clinical response to the anti-tumor necrosis factor alpha antibody infliximab in patients with ankylosing spondylitis over 3 years
  по: Baraliakos, X, et al.
  Опубликовано: (2005)
• Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor α antibody infliximab
  по: Baraliakos, X, et al.
  Опубликовано: (2005)
• Clinical response to discontinuation of anti-tumor necrosis factor therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
  по: Baraliakos, X, et al.
  Опубликовано: (2005)
• Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes
  по: Baraliakos, X, et al.
  Опубликовано: (2007)
• Two-year follow-up results after re-administration of etanercept in active ankylosing spondylitis
  по: Baraliakos, X, et al.
  Опубликовано: (2005)